|
Insider Trading: Penwest Pharmaceuticals Co
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Penwest Pharmaceuticals Co in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Penwest Pharmaceuticals Co since year 2005. Table 2 shows the detailed insider transactions of Penwest Pharmaceuticals Co since 2005.
The reporting company's ticker symbol is PPCO.
The reporting company's CIK number is 1047188.
The total value of stock buying since 2005 is $21,235,104.
The total value of stock sales is $3,757,881.
The total value of stock exercises is $1,674,909.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Penwest Pharmaceuticals Co (PPCO) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at Penwest Pharmaceuticals Co (PPCO) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Penwest Pharmaceuticals Co (PPCO).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-06 | 91,500 | 457,500 | 5,000 | 15,425 | 0 | 0 |
| 2008-05 | 5,000 | 25,000 | 4,000 | 10,540 | 0 | 0 |
| 2008-03 | 3,694,300 | 18,300,365 | 0 | 0 | 0 | 0 |
| 2008-02 | 49,100 | 260,644 | 0 | 0 | 0 | 0 |
| 2008-01 | 455,000 | 2,175,291 | 0 | 0 | 0 | 0 |
| 2007-09 | 1,500 | 16,304 | 0 | 0 | 0 | 0 |
| 2007-08 | 0 | 0 | 0 | 0 | 4,489 | 27,472 |
| 2007-05 | 0 | 0 | 0 | 0 | 1,999 | 15,012 |
| 2006-12 | 0 | 0 | 83,333 | 1,386,611 | 83,333 | 841,663 |
| 2006-09 | 0 | 0 | 3,213 | 56,388 | 0 | 0 |
| 2006-06 | 0 | 0 | 40,000 | 878,189 | 40,000 | 377,750 |
| 2006-05 | 0 | 0 | 18,363 | 368,067 | 0 | 0 |
| 2006-02 | 0 | 0 | 23,750 | 531,063 | 23,750 | 191,812 |
| 2006-01 | 0 | 0 | 17,000 | 343,286 | 17,000 | 188,020 |
| 2005-12 | 0 | 0 | 3,000 | 59,112 | 3,000 | 33,180 |
| 2005-09 | 0 | 0 | 7,000 | 109,200 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Penwest Pharmaceuticals Co (PPCO)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-06-23 | Edelman Joseph (10% Owner) | Purchase | 91,500 | 5.00 | 457,500 |
| 2008-06-10 | Freiman Paul E (Director) | Sale | 5,000 | 3.08 | 15,425 |
| 2008-05-15 | Bradley Scott (10% Owner) | Purchase | 2,500 | 5.00 | 12,500 |
| 2008-05-12 | Freiman Paul E (Director) | Sale | 4,000 | 2.64 | 10,540 |
| 2008-05-07 | Bradley Scott (10% Owner) | Purchase | 2,500 | 5.00 | 12,500 |
| 2008-03-20 | Bradley Scott (10% Owner) | Purchase | 1,340,300 | 5.83 | 7,818,416 |
| 2008-03-18 | Bradley Scott (10% Owner) | Purchase | 800 | 7.50 | 6,000 |
| 2008-03-12 | Bradley Scott (10% Owner) | Purchase | 7,400 | 5.00 | 37,000 |
| 2008-03-11 | Bradley Scott (10% Owner) | Purchase | 1,937,900 | 4.04 | 7,829,116 |
| 2008-03-10 | Bradley Scott (10% Owner) | Purchase | 342,200 | 6.67 | 2,281,333 |
| 2008-03-05 | Bradley Scott (10% Owner) | Purchase | 52,100 | 5.00 | 260,500 |
| 2008-03-04 | Bradley Scott (10% Owner) | Purchase | 13,600 | 5.00 | 68,000 |
| 2008-02-20 | Bradley Scott (10% Owner) | Purchase | 600 | 7.50 | 4,500 |
| 2008-02-19 | Bradley Scott (10% Owner) | Purchase | 1,500 | 7.50 | 11,250 |
| 2008-02-12 | Bradley Scott (10% Owner) | Purchase | 5,000 | 4.14 | 20,694 |
| 2008-02-01 | Bradley Scott (10% Owner) | Purchase | 42,000 | 5.34 | 224,200 |
| 2008-01-31 | Bradley Scott (10% Owner) | Purchase | 160,000 | 4.97 | 795,792 |
| 2008-01-30 | Bradley Scott (10% Owner) | Purchase | 170,000 | 4.74 | 806,599 |
| 2008-01-29 | Bradley Scott (10% Owner) | Purchase | 125,000 | 4.58 | 572,900 |
| 2007-09-14 | Palleiko Benjamin L (SVP, Corporate Dev. & CFO) | Purchase | 1,500 | 10.87 | 16,304 |
| 2007-08-07 | Freiman Paul E (Director) | Option Exercise | 4,489 | 6.12 | 27,472 |
| 2007-05-29 | Freiman Paul E (Director) | Option Exercise | 1,999 | 7.51 | 15,012 |
| 2006-12-11 | Hennessey Robert (Director) | Sale | 83,333 | 16.64 | 1,386,611 |
| 2006-12-11 | Hennessey Robert (Director) | Option Exercise | 83,333 | 10.10 | 841,663 |
| 2006-09-05 | Baichwal Anand (Chief Scientific Officer) | Sale | 3,213 | 17.55 | 56,388 |
| 2006-06-27 | Joslyn Alan (Sr. Vice President, R&D.) | Sale | 15,000 | 21.97 | 329,574 |
| 2006-06-27 | Joslyn Alan (Sr. Vice President, R&D.) | Option Exercise | 15,000 | 11.06 | 165,900 |
| 2006-06-26 | Joslyn Alan (Sr. Vice President, R&D.) | Sale | 10,000 | 21.78 | 217,750 |
| 2006-06-26 | Joslyn Alan (Sr. Vice President, R&D.) | Option Exercise | 10,000 | 11.06 | 110,600 |
| 2006-06-23 | Baichwal Anand (Chief Scientific Officer) | Sale | 15,000 | 22.06 | 330,865 |
| 2006-06-23 | Baichwal Anand (Chief Scientific Officer) | Option Exercise | 15,000 | 6.75 | 101,250 |
| 2006-05-08 | Baichwal Anand (Chief Scientific Officer) | Sale | 6,863 | 20.20 | 138,632 |
| 2006-05-05 | Baichwal Anand (Chief Scientific Officer) | Sale | 1,500 | 20.29 | 30,435 |
| 2006-05-01 | Freiman Paul E (Director) | Sale | 10,000 | 19.90 | 199,000 |
| 2006-02-17 | Joslyn Alan (Sr. Vice President, R&D.) | Sale | 4,000 | 23.51 | 94,032 |
| 2006-02-17 | Joslyn Alan (Sr. Vice President, R&D.) | Option Exercise | 4,000 | 10.35 | 41,400 |
| 2006-02-16 | Joslyn Alan (Sr. Vice President, R&D.) | Sale | 4,750 | 23.16 | 110,001 |
| 2006-02-16 | Joslyn Alan (Sr. Vice President, R&D.) | Option Exercise | 4,750 | 10.35 | 49,162 |
| 2006-02-03 | Baichwal Anand (Chief Scientific Officer) | Sale | 15,000 | 21.80 | 327,030 |
| 2006-02-03 | Baichwal Anand (Chief Scientific Officer) | Option Exercise | 15,000 | 6.75 | 101,250 |
| 2006-01-26 | Joslyn Alan (Sr. Vice President,) | Sale | 10,000 | 20.07 | 200,720 |
| 2006-01-26 | Joslyn Alan (Sr. Vice President,) | Option Exercise | 10,000 | 11.06 | 110,600 |
| 2006-01-05 | Joslyn Alan (Sr. Vice President,) | Sale | 5,000 | 20.51 | 102,550 |
| 2006-01-05 | Joslyn Alan (Sr. Vice President,) | Option Exercise | 5,000 | 11.06 | 55,300 |
| 2006-01-04 | Joslyn Alan (Sr. Vice President,) | Sale | 2,000 | 20.01 | 40,016 |
| 2006-01-04 | Joslyn Alan (Sr. Vice President,) | Option Exercise | 2,000 | 11.06 | 22,120 |
| 2005-12-23 | Joslyn Alan (Sr. Vice President,) | Sale | 2,000 | 19.81 | 39,612 |
| 2005-12-23 | Joslyn Alan (Sr. Vice President,) | Option Exercise | 2,000 | 11.06 | 22,120 |
| 2005-12-22 | Joslyn Alan (Sr. Vice President,) | Sale | 1,000 | 19.50 | 19,500 |
| 2005-12-22 | Joslyn Alan (Sr. Vice President,) | Option Exercise | 1,000 | 11.06 | 11,060 |
| 2005-09-08 | Baichwal Anand (Chief Scientific Officer) | Sale | 7,000 | 15.60 | 109,200 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Penwest Pharmaceuticals Co (symbol PPCO,
CIK number 1047188) see
the Securities and Exchange Commission (SEC) website.
|
|
